drugset / Trial / NCT02168595
Placebo-controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1271 in Healthy Volunteers
RandomizedSingle-groupDouble-blindOther
Summary
The purpose of this study is to evaluate safety, tolerability and pharmacokinetics of single ascending IV doses of GMI-1271 in healthy adult subjects.
Timeline
- Start
- 2014-06
- Primary completion
- 2014-08
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Uproleselan | Small molecule | 2 mg/kg | Intravenous |
| Subject | Uproleselan | Small molecule | 5 mg/kg | Intravenous |
| Subject | Uproleselan | Small molecule | 10 mg/kg | Intravenous |
Indications
No indication recorded.